Simply Wall St
2 min read
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE.
FactSet Research Systems (NYSE:FDS) has partnered with Kepler Cheuvreux to bring its Aftermarket Research onto the FactSet platform, supported by FactSet’s AI tools for European clients.
The company has also launched a beta version of AI Doc Ingest for its Cobalt product to automate private capital data workflows using AI.
FactSet Research Systems (NYSE:FDS), trading at $193.76, is rolling out these AI driven upgrades at a time when the stock has faced heavy pressure. The share price is down 14.0% over the past week and 34.7% over the past month, with a 32.0% decline year to date and a 56.8% decline over the past year.
For investors watching NYSE:FDS, these AI partnerships and product launches highlight how the company is positioning its platform for clients who need faster research and more automated data handling. The key question is how effectively FactSet converts these tools into deeper client usage and more durable workflows over time.
Stay updated on the most important news stories for FactSet Research Systems by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on FactSet Research Systems.
NYSE:FDS Earnings & Revenue Growth as at Feb 2026
📰 Beyond the headline: 1 risk and 5 things going right for FactSet Research Systems that every investor should see.
✅ Price vs Analyst Target: At US$193.76 versus a US$319.00 analyst target, the price sits about 39% below consensus.
✅ Simply Wall St Valuation: Simply Wall St estimates the shares are trading 39.5% below fair value, which is flagged as undervalued.
❌ Recent Momentum: The 30 day return of 34.7% decline shows weak short term sentiment despite the AI announcements.
There is only one way to know the right time to buy, sell or hold FactSet Research Systems. Head to Simply Wall St’s company report for the latest analysis of FactSet Research Systems’s Fair Value.
📊 The Kepler Cheuvreux partnership and AI Doc Ingest beta focus on making research access and private markets workflows stickier for existing and prospective clients.
📊 Watch how quickly these AI tools are adopted, any commentary on client usage, and whether P/E at 11.99 versus the 23.11 industry average draws in more interest.
⚠️ The key flagged risk is a high level of debt, so investors may want to see that new AI investments do not strain the balance sheet.
For the full picture including more risks and rewards, check out the complete FactSet Research Systems analysis. Alternatively, you can check out the community page for FactSet Research Systems to see how other investors believe this latest news will impact the company’s narrative.
Terms and Privacy Policy